Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients
CONCLUSION: Although we observed that the GSTP1 and RASSF1 methylation positivity rates that we examined in our study were higher in patients without prostate cancer, we found that the RASSF2 methylation rate was higher in patients with prostate cancer. randomized controlled studies are needed.PMID:38493315 | DOI:10.22037/uj.v20i.8014
Source: Urology Journal - Category: Urology & Nephrology Authors: Emre Aykanli Serdar Arisan Elif Damla Arisan Abdullah Hizir Yavuzsan Source Type: research
More News: Cancer | Cancer & Oncology | Genetics | Pathology | Prostate Cancer | Study | Urology & Nephrology